Post-approval studies (Phase 4)Study completedNCT00291876
What this trial is testing
Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month Schedule
Who this might be right for
Hepatitis A
GlaxoSmithKline 135